These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

235 related items for PubMed ID: 9216635

  • 41. Endocervical cancer is associated with an increase in the ligands and receptors for transforming growth factor-beta and a contrasting decrease in p27(Kip1).
    Farley J, Gray K, Nycum L, Prentice M, Birrer MJ, Jakowlew SB.
    Gynecol Oncol; 2000 Aug; 78(2):113-22. PubMed ID: 10926789
    [Abstract] [Full Text] [Related]

  • 42. Effect of ets-related transcription factor (ERT) on transforming growth factor (TGF)-beta type II receptor gene expression in human cancer cell lines.
    Lee HJ, Chang JH, Kim YS, Kim SJ, Yang HK.
    J Exp Clin Cancer Res; 2003 Sep; 22(3):477-80. PubMed ID: 14582709
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Decreased stability of transforming growth factor beta type II receptor mRNA in RER+ human colon carcinoma cells.
    Jiang W, Tillekeratne MP, Brattain MG, Banerji SS.
    Biochemistry; 1997 Dec 02; 36(48):14786-93. PubMed ID: 9402753
    [Abstract] [Full Text] [Related]

  • 46. Transcriptional deregulation of VEGF, FGF2, TGF-beta1, 2, 3 and cognate receptors in breast tumorigenesis.
    Soufla G, Porichis F, Sourvinos G, Vassilaros S, Spandidos DA.
    Cancer Lett; 2006 Apr 08; 235(1):100-13. PubMed ID: 15949894
    [Abstract] [Full Text] [Related]

  • 47. Frequent inactivation of the transforming growth factor beta type II receptor in small-cell lung carcinoma cells.
    de Jonge RR, Garrigue-Antar L, Vellucci VF, Reiss M.
    Oncol Res; 1997 Apr 08; 9(2):89-98. PubMed ID: 9167190
    [Abstract] [Full Text] [Related]

  • 48. Over-expression of ERT(ESX/ESE-1/ELF3), an ets-related transcription factor, induces endogenous TGF-beta type II receptor expression and restores the TGF-beta signaling pathway in Hs578t human breast cancer cells.
    Chang J, Lee C, Hahm KB, Yi Y, Choi SG, Kim SJ.
    Oncogene; 2000 Jan 06; 19(1):151-4. PubMed ID: 10644990
    [Abstract] [Full Text] [Related]

  • 49. Expression of transforming growth factor-beta receptor type II and tumorigenicity in human breast adenocarcinoma MCF-7 cells.
    Ko Y, Banerji SS, Liu Y, Li W, Liang J, Soule HD, Pauley RJ, Willson JK, Zborowska E, Brattain MG.
    J Cell Physiol; 1998 Aug 06; 176(2):424-34. PubMed ID: 9648930
    [Abstract] [Full Text] [Related]

  • 50. Induction of transforming growth factor beta 1 and its receptor expression during myeloid leukemia cell differentiation.
    Taipale J, Matikainen S, Hurme M, Keski-Oja J.
    Cell Growth Differ; 1994 Dec 06; 5(12):1309-19. PubMed ID: 7696179
    [Abstract] [Full Text] [Related]

  • 51. Overexpression of transforming growth factor beta type I receptor abolishes malignant phenotype of a rat bladder carcinoma cell line.
    Okamoto M, Oyasu R.
    Cell Growth Differ; 1997 Aug 06; 8(8):921-6. PubMed ID: 9269901
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Absence of transforming growth factor-beta responsiveness in the tamoxifen growth-inhibited human breast cancer cell line CAMA-1.
    Ji H, Stout LE, Zhang Q, Zhang R, Leung HT, Leung BS.
    J Cell Biochem; 1994 Mar 06; 54(3):332-42. PubMed ID: 8200913
    [Abstract] [Full Text] [Related]

  • 55. Induction of transforming growth factor-beta receptor type II expression in estrogen receptor-positive breast cancer cells through SP1 activation by 5-aza-2'-deoxycytidine.
    Ammanamanchi S, Kim SJ, Sun LZ, Brattain MG.
    J Biol Chem; 1998 Jun 26; 273(26):16527-34. PubMed ID: 9632722
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. Effect of anticancer drugs on production of transforming growth factor and expression of p53 AND Bcl-2 proteins by MCF-7 and T47D cell lines of human breast carcinoma.
    Stoika RS, Yakymovych IA, Kashchak NI, Boyko MM, Korynevska AV, Klyuchyvska OY, Shafranska GI, Yakymovych MY, Zhylchuk VY, Kudryavets YY, Vorontsova AL.
    Exp Oncol; 2008 Mar 26; 30(1):35-41. PubMed ID: 18438339
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Ligand-induced dimerization of the extracellular domain of the TGF-beta receptor type II.
    Letourneur O, Goetschy JF, Horisberger M, Grütter MG.
    Biochem Biophys Res Commun; 1996 Jul 25; 224(3):709-16. PubMed ID: 8713111
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.